Sen, H. N., Drye, L. T., Goldstein, D. A., Larson, T. A., Merrill, P. T., Pavan, P. R., … Jabs, D. A. (2012). Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunology and Inflammation, 20(2), 104–112. https://doi.org/10.3109/09273948.2011.647228

Sen, H Nida, Lea T. Drye, Debra A. Goldstein, Theresa A. Larson, Pauline T. Merrill, Peter R. Pavan, John D. Sheppard, Alyce Burke, Sunil K. Srivastava, and Douglas A. Jabs. “Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.” Ocular Immunology and Inflammation 20, no. 2 (April 2012): 104–12. https://doi.org/10.3109/09273948.2011.647228.

Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, et al. Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunology and Inflammation. 2012 Apr;20(2):104–12.

Sen, H. Nida, et al. “Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.” Ocular Immunology and Inflammation, vol. 20, no. 2, Informa UK Limited, Apr. 2012, pp. 104–12. Crossref, doi:10.3109/09273948.2011.647228.

Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA. Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunology and Inflammation. Informa UK Limited; 2012 Apr;20(2):104–112.